Asper Reprogenetics is a brand name of portfolio of tests targeting reproduction related and prenatal conditions.
Prenatal diagnostics is highly essential for severe life-threatening conditions in order to make decisions for early treatment options in case of curable disorders and to give feedback to parents of genetic condition of the fetus. Our tests enable identification of aberrant arrangement of genetic material that could cause serious diseases as well as detection of inherited malformations and carrier status of various traits. Most of analyses are performed using robust APEX-based approach that enables fast, reliable, simultaneous and cost-effective detection of hundreds of disease related mutations and alterations in multiple genes. In addition to APEX-based testing next generation sequencing is also used in case of the majority of the disorders.
Our portfolio comprises unique up-to-date tests for implementation to individuals from different populations all over the world. Elaboration and development of tests is carried out by our experienced scientific staff in collaboration with international outstanding scientists.
Ashkenazi Jewish diseases
Congenital Adrenal Hyperplasia
Cystic Fibrosis – CF
FGFR2 gene mutation analysis NEW
FGFR3 gene mutation analysis NEW
Syndromes related to increased Nuchal Translucency of fetus
Venous Thrombosis risk assessment – VT